Crosstalk between HER2 and PD-1/PD-L1 in Breast Cancer: From Clinical Applications to Mathematical Models

Breast cancer is one of the major causes of mortality in women worldwide. The most aggressive breast cancer subtypes are human epidermal growth factor receptor-positive (HER2(+)) and triple-negative breast cancers. Therapies targeting HER2 receptors have significantly improved HER2(+) breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Padmanabhan, Regina, Kheraldine, Hadeel Shafeeq, Meskin, Nader, Vranic, Semir, Al Moustafa, Ala-Eddin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139939/
https://www.ncbi.nlm.nih.gov/pubmed/32164163
http://dx.doi.org/10.3390/cancers12030636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139939/
https://www.ncbi.nlm.nih.gov/pubmed/32164163
http://dx.doi.org/10.3390/cancers12030636

Ejemplares similares